Jupiter Orphan Therapeutics' Convertible Note Round

Jupiter Orphan Therapeutics raised a round of funding on January 05, 2017. Investors include Tarnagulla Ventures.

Jupiter Orphan Therapeutics (JOT) is a specialty pharmaceutical company developing therapies for rare diseases linked to single gene deficiencies. JOT, a Delaware Corporation with it's principal offic…

Articles about Jupiter Orphan Therapeutics' Convertible Note Round: